Angiotensin II Type 2 Receptor Stimulation
Diagnostic Imaging
Inflammation
Dose-Response Relationship, Drug
Hemodynamics
Myocardial Infarction
Apoptosis
Receptor, Angiotensin, Type 2
Rats
3. Good health
Renin-Angiotensin System
03 medical and health sciences
0302 clinical medicine
Animals
Rats, Wistar
DOI:
10.1161/circulationaha.108.784868
Publication Date:
2008-11-25T02:37:51Z
AUTHORS (22)
ABSTRACT
Background— This study is the first to examine effect of direct angiotensin II type 2 (AT ) receptor stimulation on postinfarct cardiac function with use novel nonpeptide AT agonist compound 21 (C21). Methods and Results— Myocardial infarction (MI) was induced in Wistar rats by permanent ligation left coronary artery. Treatment C21 (0.01, 0.03, 0.3 mg/kg per day IP) started 24 hours after MI continued until euthanasia (7 days MI). Infarct size assessed magnetic resonance imaging, hemodynamic measurements were performed via transthoracic Doppler echocardiography intracardiac Millar catheter. Cardiac tissues analyzed for inflammation apoptosis markers immunoblotting real-time reverse transcription polymerase chain reaction. significantly improved systolic diastolic ventricular function. Scar smallest C21-treated rats. In regard underlying mechanisms, diminished MI-induced Fas-ligand caspase-3 expression peri-infarct zone, indicating an antiapoptotic effect. Phosphorylation p44/42 p38 mitogen-activated protein kinases, both involved regulation cell survival, strongly reduced but almost completely rescued treatment. Furthermore, decreased serum monocyte chemoattractant protein-1 myeloperoxidase as well interleukin-6, interleukin-1β, interleukin-2 expression, suggesting antiinflammatory Conclusions— Direct may be a therapeutic approach improve post-MI mechanisms.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (24)
CITATIONS (224)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....